A Comparative Study between the Effects of 308-nm Excimer light and Narrow-Band Ultraviolet B in the Treatment of Vitiligo

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201705002279419

Enrollment

Registered

2017-05-08

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases vitiligo

Interventions

phototherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ¿ Patient¿s age more than 18 years ¿ Patients suffering from non-segmental Vitiligo (confirmed using Wood¿s light)

Exclusion criteria

Exclusion criteria: ¿ Patients with localized, segmental, genital or axillary vitiligo. ¿ Patients with light sensitive or aggravated dermatoses. ¿ Patients with or giving a past history of melanoma or any NMSC. ¿ Patients with aphakia or cataract. ¿ Patients with abnormal liver or renal functions. ¿ Pregnant or lactating female patients. ¿ Patients who received treatment for vitiligo within the last 6 months.

Design outcomes

Primary

Measure	Time frame
effect of NBUVB on vitiligo;effect of MEL on vitiligo	—

Secondary

Measure	Time frame
side effects	—

Countries

Egypt

Contacts

Public Contactmanal salah

professor of dermatology

m.salah.2000@hotmail.com01001873225

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026